Nexus Surgical and Medicare
- Market cap
- ₹ 14 Cr.
- P/E
- 15.1x
- P/B
- 8.01x
- 52-week range
- 13.26 – 35.79
- ROE
- 52%
- ROCE
- 69.2%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Finance
- Industry
- Other Financial Services
- Listed on
- BSE
About
Nexus Surgical and Medicare Limited is an India-based company, which is engaged in the trading business. The Company is involved in importing and marketing surgical and pharmaceutical products. The Company is a wholesale dealer dealing in various sizes of disposal syringe (with and without needle) and pouches of various sizes used for storage of sterilized equipment and material.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Other Financial Services: 120 companies →Nexus Surgical and Medicare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)15.1 against a typical 30.9: cheaper than most peers (1st = cheapest).31st of 119
- Sales growth+47.4% against a typical +10.4% from a year earlier.29th of 93
- Profit growth+33.3% against a typical −1.6% from a year earlier.31st of 85
- Share price, 3 months+14.7% against a typical −4.8%.15th of 97
- Size₹ 13.8 Cr. market value against a typical ₹ 35.5 Cr. (1st = largest).86th of 113
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 3 | 2 | 3 |
| Expenses | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 3 | 2 | 2 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| OPM % | 24.3% | 3.5% | 13.3% | 6.8% | 28.3% | 10.1% | 7.4% | 11.6% | 19.7% | 7.5% | 14.6% | 9.4% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 27.3% | 33.3% | 25% | 25% | 25% | 26.7% | 25% | 25% | 26.1% | 26.1% | 25% | 25.9% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | 0.15 | 0.09 | 0.11 | 0.16 | 0.38 | 0.2 | 0.16 | 0.27 | 0.31 | 0.31 | 0.44 | 0.37 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 37%
- 5 Years
- 16%
- 3 Years
- 72%
- TTM
- 53%
- 10 Years
- 31%
- 5 Years
- 38%
- 3 Years
- 63%
- TTM
- 39%
- 10 Years
- −10%
- 5 Years
- 45%
- 3 Years
- 24%
- TTM
- —
- 10 Years
- —
- 5 Years
- 64%
- 3 Years
- 54%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Nexus Surgical and Medicare | ₹ 21.48 | ₹ 14 Cr. | 15.1x | 8x | 52% | — |
| Delhivery | ₹ 370.00 | ₹ 27,724 Cr. | 226x | 3.8x | 1.6% | 1.5% |
| Urban Company | ₹ 132.65 | ₹ 20,457 Cr. | — | 8.9x | −11.9% | −15.1% |
| Indegene | ₹ 570.00 | ₹ 13,763 Cr. | 29.5x | 3.9x | 13.9% | 11.4% |
| BLS International Services | ₹ 208.70 | ₹ 8,593 Cr. | 14.2x | 3.9x | 32.7% | 24.1% |
| Axiscades Technologies | ₹ 1,915.00 | ₹ 8,154 Cr. | 83.3x | 9.1x | 10.5% | 6.2% |
Management
- Pawankumar Sitaram Choudhary
- Chief Financial Officer, Additional Executive Director
- Monika Choudhary
- Compliance Officer, Company Secretary
- Ram Swaroop Mahadev Joshi
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.